CIK 0001213037 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 593000 | 488000 | 386000 | |
| Net income (USD) | -38.7 M | -28.3 M | ||
| Diluted EPS (USD/shares) | -0.69 | -0.93 | -0.89 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-14 | 8-K | 8-K items 1.01,7.01,9.01 | 2026-09-14 |
| 2026-08-26 | DEFA14A | DEFA14A | |
| 2026-08-26 | DEF 14A | DEF 14A | 2026-08-26 |
| 2026-08-14 | PRE 14A | PRE 14A | 2026-08-14 |
| 2026-08-11 | 8-K | 8-K items 2.02,9.01 | 2026-08-11 |
| 2026-08-11 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-27 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-21 | S-8 | S-8 | |
| 2026-07-16 | 4 | 4 | 2026-07-14 |
| 2026-07-16 | 4 | 4 | 2026-07-14 |
| 2026-07-16 | 8-K | 8-K items 1.01,8.01,9.01 | 2026-07-14 |
| 2026-07-16 | 424B5 | 424B5 | |
| 2026-06-22 | 4 | 4 | 2026-06-18 |
| 2026-06-22 | 4 | 4 | 2026-06-18 |
| 2026-06-15 | 4 | 4 | 2026-06-11 |
| 2026-06-15 | 4 | 4 | 2026-06-11 |
| 2026-06-15 | 4 | 4 | 2026-06-11 |
| 2026-06-15 | 4 | 4 | 2026-06-11 |
| 2026-06-15 | 4 | 4 | 2026-06-11 |
| 2026-06-11 | 8-K | 8-K items 5.07 | 2026-06-11 |
| 2026-06-03 | 8-K | 8-K items 7.01 | 2026-06-03 |
| 2026-05-29 | 8-K | 8-K items 1.01 | 2026-05-27 |
| 2026-05-19 | 8-K | 8-K items 8.01 | 2026-05-19 |
| 2026-05-14 | 8-K | 8-K items 2.02,9.01 | 2026-05-14 |
| 2026-05-14 | 10-Q | 10-Q | 2026-03-31 |
Forms on file (last 1,000): 8-K 394, 4 240, 10-Q 43, SC 13G 27, SC 13G/A 27, CORRESP 25, 3 24, DEFA14A 21. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CRDF (0.002 USD), /gw/filings/filings?ticker=CRDF&form=8-K, /gw/filings/facts?ticker=CRDF&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange